Abstract
Since 1918, influenza virus has been one of the major causes of morbidity and mortality, especially among young children. Though the commonly circulating strain of the virus is not virulent enough to cause mortality, the ability of the virus genome to mutate at a very high rate may lead to the emergence of a highly virulent strain that may become the cause of the next pandemic. Apart from the influenza virus strain circulating in humans (H1N1 and H3N2), the avian influenza H5N1 H7 and H9 virus strains have also been reported to have caused human infections, H5N1 H7 and H9 have shown their ability to cross the species barrier from birds to humans and further replicate in humans. This review addresses the biological and epidemiological aspects of influenza virus and efforts to have a control on the virus globally.
Article PDF
Similar content being viewed by others
References
Abed Y, Goyette N and Boivin G 2005 Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations; Antimicrob. Agents Chemother. 49 556–559
Areechokchai D, Jiraphongsa C, Laosiritaworn Y, Hanshaoworakul W and O’Reilly M 2006 Investigation of avian influenza (H5N1) outbreak in humans—Thailand, 2004; Morb. Mortal. Wkly Rep. 55 3–6
Belshe R B, Gruber W C, Mendelman P M Mehata H B, Mahmood K Reisinger K, Treanor J, Zangwill K, et al 2000a Correlates of imune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine; J. Infect. Dis. 181 1133–1137
Belshe R B, Gruber W C, Mendelman P M, Cho I, Reisinger K, Block S L, Wittes J, Iacuzio D, et al 2000b Efficacy of vaccination with live atteuated, cold adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sidney) not contained in the vaccine; J. Pediatr. 136 168–175
Belshe R B, Smith H M, Hall C B, Betts R and Hay A J 1988 Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection; J. Virol. 62 1508–1512
Bridges C B, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak K H, Rowe T, Thompson W W, et al 2002 Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997–1998; J. Infect. Dis. 185 1005–1010
Brumback B G and Wade C D 1996. Simultaneous rapid culture for four respiratory viruses in the same cell monolayer using a differential multicolored fluorescent confirmatory stain; J. Clin. Microbiol. 34 798
Call S, Vollenweider M, Hornung C, Simel D and McKinney W 2005 Does this patient have influenza?; JAMA 293 987
Davies F G, Casals J, Jesset D M and Ochieng P 1978 The serological relationships of Nairobi sheep disease virus; J. Comp. Pathol. 88 519
Demicheli V, Jefferson T, Rivet D and Deeks J 2000 Prevention and early treatment of influenza in healthy adults; Vaccine. 18 957–1030
Dinh P N, Long H T, Tien N T, Hien N T et al 2006 Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004; Emerg. Infect. Dis. 12 1841–1847
Dunnil P A 2006 DNA flu vaccine in practice; Nat. Biotechnol. 24 139
Eccles R 2005 Understanding the symptoms of the common cold and influenza; Lancet Infect. Dis. 5 718
Elveback L R., Fox J P and Ackerman E 1976 An influenza simulation model for immunization studies; Am. J. Epidemiology. 103 152
Gubareva L V, McCullers J A, Bethell R C and Webster R G 1998 Characterization of influenza A/Hong Kong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice; J. Infect. Dis. 178 1592
Hayden F G and Hay A J 1992 Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine; Curr. Top. Microbiol. Immunol. 176 119–130
Hilleman M 2002 Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control; Vaccine 20 3068–3087
Hirst G K 1941 Agglutination of red cells by amniotic fluid of chick embryos infected with influenza virus; Science 94 22
Hoffmann E, Mahmood K, Chen Z, Yang C-F, Spaete J, Greenberg H B, Herlocher M L, Jin H and Kemble G 2005 Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/ 1/66; J. Virol. 79 11014–11021
Hui D C 2008 Influenza A/H5N1 infection: Other treatment options and issues; Respirology 13 S22–S26
Hui D S C 2008 Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection; Respirology 13 S10–S13
Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang C F, Kenble G and Greenberg H 2003 Multiple amino acid residues confer temperature sensitivity to influenza virus vaccine strains (FluMist) derived from cold adapted A/Ann Arbor/ 6/60; Virology 306 18–24
Kandun I N, Wibisono H, Sedyaningsih E R, Yusharmen, Hadisoedarsuno W, Purba W, Santoso H, Septiawati C, et al 2006 Three Indonesian clusters of H5N1 virus infection in 2005; N. Engl. J. Med. 355 2186–2194
Kawaoka Y, Krauss S and Webster R G 1989 Avian to human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics; J. Virol. 63 4603
Kaneko H, Kawana T, Fukushima E and Suzutani T 2007 Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances; J. Biochem. Biophys. Methods 70 499
Kerr A A, McQuillin J, Downham M A and Gardner P S 1975 Gastric flu influenza B causing abdominal symptons in children; Lancet 1 291
Khanna M and Kumar P 2002 Influenza: A serious global threat; J. Infect. Dis. Antimicro Agents 19 25
Khanna M and Srivastava V 2006 Clinical laboratory diagnosis of influenza; Adv. Med. Veter. Virol. Immunol. Epidemiol. 6 138
La Spada A R, Wilson E M, Lubahn D B, Harding A E and Fischbeck K H 1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy; Nature (London) 352 77
Lee C W and Suarez D L 2004. Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus; J. Virol. Methods 119 151
Mathew T M 2006 Epidemiology of influenza A, B and C; Adv. Med. Veter. Virol. Immunol. Epidemiol. 6 24
McElhaney J, Beattie B L, Devin R, Grynoch R, Toth E L and Bleackely R C 1990 Age related decline in interleukin 2 production in response to influenza vaccine; J. Am. Geriatr. Soc. 38 652–658
Ministry of Health. U K 1920 Report on the pandemic of influenza, 1918–19; Rep. Health Med. Subjects 4 182
Monto A S, Robinson D P, Herlocher M L, Hinson J M, Elliott M J and Crisp A 1999 Zanamivir in the prevention of influenza among healthy adults; JAMA 282 31–35
Olsen S J, Ungchusak K, Sovann L, Uyeki T M, Dowell S F, Cox N J, Aldis W and Chunsuttiwat S 2005 Family clustering of avian influenza A (H5N1); Emerg. Infect. Dis. 11 1799–801
Orskov I and Orskov F 1990 Serologic classification of fimbriae; Curr. Top. Microbiol. Immunol. 151 71
Osterholm M T 2005 Preparing for the next pandemic; N. Engl. J. Med. 352 1839
Palese P 2004 Influenza: Old and new threats; Nat. Med. 10 S82
Poon L L M, Leung C S W, Chan K H, Lee J H C, Yuen K Y, Guan Y and Peiris J S M 2005 Detection of human influenza A viruses by loop-mediated isothermal amplification; J. Clin. Microbiol. 43 427
Ridley R G 2004 Research on infectious diseases requires better coordination; Nat. Med. 10 S137
Schmitz N, Kurrer M, Bachmann M and Kopf M 2005 Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection; J. Virol. 79 6441
Sedyaningsih E R, Isfandari S, Setiawaty V, Rifati L, Harun S, Purba W, Blair P J, Putman S D, et al 2007 Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005–June 2006; J. Infect. Dis. 196 522–527
Stephenson I, Nicholson K G, Wood J M, Zambon M C and Katz J M 2004 Confronting the avian influenza threat; vaccine development for a potential pandemic; Lancet 4 499
Stockton J, Ellis J S, Saville M, Clewley J P and Zambon M C 1998 Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses; J. Clin. Microbiol. 36 2990
Tambyah PA 2008 Update on influenza vaccines; Respirology 13 S41–S43
Trani L D, Bedini B, Donatelli I, Campitelli L, Chiappini B, Marco M A, Delogu M, Buonavoglia C and Vaccari G 2006 A sensitive one-step real-time PCR for detection of avian influenza viruses using a MGB probe and an internal positive control; BMC Infect. Dis. 6 87
Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthaathana P, Uipraserkul M, Boonnak K, et al 2005 Probable person-to-person transmission of avian influenza A (H5N1); N. Engl. J. Med. 352 333–340
Wang C, Takeuchi K, Pinto L H and Lamb R A 1993. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block; J. Virol. 67 5585
Webby R J and Webster R G 2003 Are we ready for pandemic influenza?; Science 302 1519
World Health Organization 2005 Avian influenza: Assessing the pandemic threat (Geneva)
World Health Organization 2007 Clinical management of human infection with avian influenza A (H5N1) virus. Updated advice 15 August available from http://www.who.int/csr/disease/avian_influenza/guidelines/ClinicalManagement07.pdf
World Health Organization 2006 Recommendations and laboratory procedures for detection of avian influenza A (H5N1) virus in specimens from suspected human cases. available from http://www.who.int/csr/disease/avian_influenza/guidelines/RecAIlabtestsAug07pdf
World Health Organization 2008 Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO — available from URL: http://www.who.int/csr/disease/avian_influenza/country/cases_table_2008_01_11/en/print.html
World Health Organization. Update 2007 WHO-confirmed human cases of avian influenza A (H5N1) infection; Wkly. Epidemiol. Rec. 82 41–47
Wright K E, Wilson G A R, Novosad D, Dimock C, Tan D and Weber J M 1995 Typing and subtyping of influenza viruses in clinical samples by PCR; J. Clin. Microbiol. 33 1180–1184
Writing committee of the second World Health Organization 2008 Consultation on clinical aspects of human infection with avian influenza A (H5N1) virus. Update on avian influenza A (H5N1) virus infection in humans; N. Engl. J. Med. 358 261–73
Uyeki T M 2008 Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses; Respirology 13 S2–S9
Yu H, Feng Z, Zhang X, Xiang N, Huai Y and Zhou L 2007 Human influenza A (H5N1) cases, urban areas of people’s Republic of China, 2005–2006; Emerg. Infect. Dis. 13 1061–1065